Latest Articles
-
Better Value & Growth: RMD, BDX Lead Abbott Laboratories Stock
RMD, BDX are Abbott Laboratories’s peers in Health Care Equipment industry that have: 1) Lower valuation (P/OpInc) compared to Abbott Laboratories stock 2) But higher revenue and operating income growth This disconnect between valuation a...
-
RMD, BDX Top Abbott Laboratories Stock on Price & Potential
RMD, BDX are Abbott Laboratories’s peers in Health Care Equipment industry that have: 1) Lower valuation (P/OpInc) compared to Abbott Laboratories stock 2) But higher revenue and operating income growth This disconnect between valuation a...
-
Better Value & Growth: RMD, BDX Lead Abbott Laboratories Stock
RMD, BDX are Abbott Laboratories’s peers in Health Care Equipment industry that have: 1) Lower valuation (P/OpInc) compared to Abbott Laboratories stock 2) But higher revenue and operating income growth This disconnect between valuation a...
-
Pay Less, Grow More: RMD, BDX Outshine Abbott Laboratories Stock
RMD, BDX are Abbott Laboratories’s peers in Health Care Equipment industry that have: 1) Lower valuation (P/OpInc) compared to Abbott Laboratories stock 2) But higher revenue and operating income growth This disconnect between valuation a...
-
Better Bet Than Abbott Laboratories Stock: Pay Less To Get More From RMD, BDX
RMD, BDX are ABT’s peers in Health Care Equipment industry that have: 1) Lower valuation (P/OpInc) compared to ABT 2) But higher revenue and operating income growth This disconnect between valuation and performance could mean that you are...
-
Better Bet Than Abbott Laboratories Stock: Pay Less To Get More From RMD, BDX
RMD, BDX are ABT’s peers in Health Care Equipment industry that have: 1) Lower valuation (P/OpInc) compared to ABT 2) But higher revenue and operating income growth This disconnect between valuation and performance could mean that you are...
-
Better Bet Than Abbott Laboratories Stock: Pay Less To Get More From RMD, BDX
RMD, BDX are ABT’s peers in Health Care Equipment industry that have: 1) Lower valuation (P/OpInc) compared to ABT 2) But higher revenue and operating income growth This disconnect between valuation and performance could mean that you are...
-
ABT Stock Up 6.4% after 6-Day Win Streak
Abbott Laboratories (ABT) stock hit day 6 of a continuous streak of days with gains, with cumulative gains over this period amounting to a 6.4% return. The company has gained about $15 Bil in value over the last 6 days, with its current market ca...
-
Better Bet Than Abbott Laboratories Stock: Pay Less To Get More From GMED, RMD
GMED, RMD are ABT’s peers in Health Care Equipment industry that have: 1) Lower valuation (P/EBIT) compared to ABT 2) But higher revenue and operating income growth This disconnect between valuation and performance could mean that you are...
-
Better Bet Than Abbott Laboratories Stock: Pay Less To Get More From GMED, RMD
GMED, RMD are ABT’s peers in Health Care Equipment industry that have: 1) Lower valuation (P/EBIT) compared to ABT 2) But higher revenue and operating income growth This disconnect between valuation and performance could mean that you are...
-
Better Bet Than Abbott Laboratories Stock: Pay Less To Get More From ALC, RMD
ALC, RMD are ABT’s peers in Health Care Equipment industry that have: 1) Lower valuation (P/EBIT) compared to ABT 2) But higher revenue and operating income growth This disconnect between valuation and performance could mean that you are ...
-
After ABT’s 8.5% Single Day Slide, EW Looks Like the Stronger Long-Term Play
EW offers superior revenue growth across key periods, better profitability, and an attractive valuation. EW’s quarterly revenue grew 6.2%, vs. ABT’s 4.0%. In addition, its Last 12 Months growth came in at 7.9%, ahead of ABT’s...
-
ABT Down 8.5% In A Day. It Dropped More in 2008.
In Dot-Com Bubble, Abbott Laboratories stock declined 44% vs 37% for S&P 500. During inflation shock, it dropped 36% compared to the S&P 500’s 25%. Following the Inflation Shock, the stock has not yet recovered to its pre-crisis...
-
S&P 500 Movers | Winners: SNA, ALB, PEP | Losers: ELV, ABT, MOH
On Thursday, July 17, markets rallied broadly, with the S&P 500 rising 0.54%, the Dow 30 rising 0.52%, and the Nasdaq 100 rising 0.76%. While many stocks participated in the rally, some lagged behind. List of S&P 500 Winners The follo...
-
Should You Buy or Sell Abbott Laboratories Stock Ahead of Its Upcoming Earnings?
Abbott Laboratories (NYSE:ABT) is set to release its second-quarter earnings on Thursday, July 17, 2025. For event-driven traders, analyzing the stock’s historical reactions to earnings reports can provide valuable insights. Looking at the...
